ACC 2017

The 66th Scientific Session of the American College of Cardiology will bring together cardiovascular professionals from across the globe to meet in Washington, DC, from March 17-19, 2017. The annual conference now features an additional full day of groundbreaking research presentations, debates, and intensive sessions on the most cutting-edge topics in cardiology. Sign up for our daily e-mail blasts, and check back here during the conference for the full coverage.

Coverage

   |   
At the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.
   |   
A double dose of inclisiran reduced LDL cholesterol up to 52.6%.
   |   
Discrepancies found when comparing real-world findings to clinical trial findings.
   |   
Preliminary trial finds moderate-intensity exercise does not increase adverse events in this patient population.
   |   
Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.
   |   
Study compares common treatment options to prevent recurrent venous thromboembolism.
   |   
Complications associated with left main bifurcation can impact stent choice.
   |   
A multi-faceted screening approach could prevent sudden cardiac deaths in young athletes.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$